Denying contraceptive choice to women with a previous ectopic pregnancy

Journal of Family Planning and Reproductive Health Care

Volumn 43, Issue 3, 2017, Pages 232-233

  Mansour, Diana J ^a   Percy, Laura ^b  

^a New Croft Centre   (United Kingdom)

^b Conifer House ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; DESOGESTREL; ETONOGESTREL; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; PROGESTERONE;

ABORTION; CONTRACEPTION; CONTRACEPTIVE BEHAVIOR; DYING; ECTOPIC PREGNANCY; EMERGENCY WARD; FEMALE; GYNECOLOGIST; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; INTERNAL ILIAC ARTERY; INTRAUTERINE CONTRACEPTIVE DEVICE; LAPAROSCOPIC SURGERY; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; NOTE; PREGNANCY; PROSPECTIVE STUDY; STUDY; VAGINA RING;

EID: 85022085256     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1136/jfprhc-2016-101700     Document Type: Note

References (11)

1. Williams S, Peipert J, Buckel C, et al. Contraception and the risk of ectopic pregnancy. Contraception 2014;90:326.
2. Power J, French R, Cowan F. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods for preventing pregnancy. Cochrane Database Syst Rev 2007;3:CD001326.
3. Faculty of Sexual & Reproductive Healthcare. UK Medical Eligibility Criteria for Contraceptive Use. UKMCE. 2016. https://www.fsrh.org/standards-and-guidance/documents/ukmec-2016/016 (accessed on 11 Feb 2017).
4. Cleland K, Raymond E, Trussell J, et al. Ectopic pregnancy and emergency contraceptive pills: a systematic review. Obstet Gynecol 2010;115:1263-6.
5. Glasier AF, Cameron ST, Fine PM, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet 2010;375:555-62.
6. Trabert B, Holt VL, Yu O, et al. Population-based ectopic pregnancy trends, 1993-2007. Am J Prev Med 2011;40:556-60.
7. Winner B, Peipert JF, Zhao Q, et al. Effectiveness of long-acting reversible contraception. N Engl J Med 2012;366:1998-2007.
8. Broome M, Fotherby K. Clinical experience with the progestogen-only pill. Contraception 1990;42:489-95.
9. Collaborative Study Group on the Desogestrel-containing Progestogen-only Pill. A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms/day or levonorgestrel 30 micrograms/day. Eur J Contracept Reprod Health Care 1998;3:169-78.
10. Heinemann K, Reed S, Moehner S, et al. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices. Contraception 2015;91:280-3.
11. Nelson A, Apter D, Hauck B, et al. Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial. Obstet Gynecol 2013;122:1205-13.